Literature DB >> 30192657

Timely Antiviral Administration During an Influenza Pandemic: Key Components.

Lisa M Koonin1, Anita Patel1.   

Abstract

Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response. This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic. Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30192657      PMCID: PMC6129661          DOI: 10.2105/AJPH.2018.304609

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  21 in total

1.  The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).

Authors:  Jean Clare Smith
Journal:  Vaccine       Date:  2010-04-19       Impact factor: 3.641

2.  Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season.

Authors:  Mark R Mueller; Philip J Smith; Joan P Baumbach; John P Palumbo; James I Meek; Ken Gershman; Meredith Vandermeer; Ann R Thomas; Christine E Long; Ruth Belflower; Nancy L Spina; Karen G Martin; Ruth Lynfield; Kyle P Openo; Pamala D Kirley; Lauren E Pasutti; Brenda G Barnes; William Schaffner; Laurie Kamimoto
Journal:  Ann Emerg Med       Date:  2010-01       Impact factor: 5.721

3.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.

Authors:  Justin J O'Hagan; Karen K Wong; Angela P Campbell; Anita Patel; David L Swerdlow; Alicia M Fry; Lisa M Koonin; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

5.  Editorial commentary: failing our patients by suboptimally treating influenza infections.

Authors:  Michael G Ison
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

6.  Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.

Authors:  Yon Yu; Shikha Garg; Patricia A Yu; Hye-Joo Kim; Anita Patel; Toby Merlin; Stephen Redd; Timothy M Uyeki
Journal:  Clin Infect Dis       Date:  2012-04-05       Impact factor: 9.079

7.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Authors:  Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

8.  Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Authors:  Alicia M Fry; Doli Goswami; Kamrun Nahar; Amina Tahia Sharmin; Mustafizur Rahman; Larisa Gubareva; Tasnim Azim; Joseph Bresee; Stephen P Luby; W Abdullah Brooks
Journal:  Lancet Infect Dis       Date:  2013-11-22       Impact factor: 25.071

9.  Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016.

Authors:  Rebekah J Stewart; Brendan Flannery; Jessie R Chung; Manjusha Gaglani; Michael Reis; Richard K Zimmerman; Mary Patricia Nowalk; Lisa Jackson; Michael L Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Alicia M Fry; Fiona P Havers
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 20.999

Review 10.  A systematic review of factors affecting intended and actual adherence with antiviral medication as treatment or prophylaxis in seasonal and pandemic flu.

Authors:  Louise E Smith; Donatella D'Antoni; Vageesh Jain; Julia M Pearce; John Weinman; G James Rubin
Journal:  Influenza Other Respir Viruses       Date:  2016-08-08       Impact factor: 4.380

View more
  5 in total

Review 1.  Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data.

Authors:  Razina Rouf; Shaikh Jamal Uddin; Dipto Kumer Sarker; Muhammad Torequl Islam; Eunus S Ali; Jamil A Shilpi; Lutfun Nahar; Evelin Tiralongo; Satyajit D Sarker
Journal:  Trends Food Sci Technol       Date:  2020-08-19       Impact factor: 12.563

Review 2.  The evolution and future of influenza pandemic preparedness.

Authors:  Walter N Harrington; Christina M Kackos; Richard J Webby
Journal:  Exp Mol Med       Date:  2021-05-06       Impact factor: 8.718

3.  Wearable sensor-based detection of influenza in presymptomatic and asymptomatic individuals.

Authors:  Dorota S Temple; Meghan Hegarty-Craver; Robert D Furberg; Edward A Preble; Emma Bergstrom; Zoe Gardener; Peter Dayananda; Lydia Taylor; Nana Marie Lemm; Lukas Papargyris; Micah T McClain; Bradly P Nicholson; Aleah Bowie; Maria Miggs; Elizabeth Petzold; Christopher W Woods; Christopher Chiu; Kristin H Gilchrist
Journal:  J Infect Dis       Date:  2022-06-27       Impact factor: 7.759

4.  Outpatient Antibiotic and Antiviral Utilization Patterns in Patients Tested for Respiratory Pathogens in the United States: A Real-World Database Study.

Authors:  Jenny Tse; Aimee M Near; Mindy Cheng; James Karichu; Brian Lee; Susan N Chang
Journal:  Antibiotics (Basel)       Date:  2022-08-04

Review 5.  Targeting Viral Surface Proteins through Structure-Based Design.

Authors:  Yogesh B Narkhede; Karen J Gonzalez; Eva-Maria Strauch
Journal:  Viruses       Date:  2021-07-08       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.